SUBSEQUENT EVENTS	12 Months Ended
Dec. 31, 2013
Notes to Financial Statements
Note 10. SUBSEQUENT EVENTS	On January 30, 2014, the Company entered into a securities purchase agreement with an accredited investor (the “January 2014 Accredited Investor”) pursuant to which the January 2014 Accredited Investor purchased 1,818,182 shares of the Company’s common stock (the “Shares”) and a warrant to acquire 909,091 shares of common stock (the "Warrant" and together with the Shares, the "Securities") for a purchase price of $100,000 (the "Funds"). The Warrant is exercisable for five (5) years at an exercise price of $0.085 per share. The Funds were received by the Company on January 22, 2014. On February 4, 2014 and February 10, 2014, Manhattan Scientifics, Inc. (the “Company”) entered into securities purchase agreements with two accredited investors (the “February 2014 Accredited Investors”) pursuant to which the February 2014 Accredited Investors purchased 18,250,000 shares of the Company’s common stock (the “Shares”) and warrants to acquire 4,562,500 shares of common stock (the "Warrants" and together with the Shares, the "Securities") for an aggregate purchase price of $1,368,750 (the "Funds"). The Warrants are exercisable for five (5) years at an exercise price of $0.075 per share. The Funds were received by the Company on February 7, 2014 and February 11, 2014 in the amount of $1,125,000 and $243,750, respectively. During March 2014, the Company issued 2,533,334 shares of common stock to two consultants for services with a total value $177,000. During March 2014, the Company issued 1,818,182 shares of common stock in a private offering to two parties for cash totaling $100,000.

SUBSEQUENT EVENTS

12 Months Ended

Dec. 31, 2013

On January 30, 2014, the Company entered into a securities purchase agreement with an accredited investor (the “January 2014 Accredited Investor”) pursuant to which the January 2014 Accredited Investor purchased 1,818,182 shares of the Company’s common stock (the “Shares”) and a warrant to acquire 909,091 shares of common stock (the "Warrant" and together with the Shares, the "Securities") for a purchase price of $100,000 (the "Funds"). The Warrant is exercisable for five (5) years at an exercise price of $0.085 per share. The Funds were received by the Company on January 22, 2014.

On February 4, 2014 and February 10, 2014, Manhattan Scientifics, Inc. (the “Company”) entered into securities purchase agreements with two accredited investors (the “February 2014 Accredited Investors”) pursuant to which the February 2014 Accredited Investors purchased 18,250,000 shares of the Company’s common stock (the “Shares”) and warrants to acquire 4,562,500 shares of common stock (the "Warrants" and together with the Shares, the "Securities") for an aggregate purchase price of $1,368,750 (the "Funds"). The Warrants are exercisable for five (5) years at an exercise price of $0.075 per share. The Funds were received by the Company on February 7, 2014 and February 11, 2014 in the amount of $1,125,000 and $243,750, respectively.

During March 2014, the Company issued 2,533,334 shares of common stock to two consultants for services with a total value $177,000.

During March 2014, the Company issued 1,818,182 shares of common stock in a private offering to two parties for cash totaling $100,000.